Cincor pharma linkedin
WebNov 28, 2024 · Cincor Pharma drug baxdrostat failed its Phase 2 test, falling short of the goal of reducing blood pressure in patients with uncontrolled hypertension. But results in a subgroup of patients showed ... WebView Catherine J. Pearce, MBA, DHSc’s profile on LinkedIn, the world’s largest professional community. Catherine J. has 2 jobs listed on their profile. See the complete ...
Cincor pharma linkedin
Did you know?
WebAbout. A biology research engineer, with experience as a microbiology laboratory technician in pharmaceutical environment and experience in research laboratory in microbiology and molecular biology. My goal is to find a laboratory that can bring me a rewarding experience, but where, I can also contribute in the success and the accomplishment of ... WebFeb 23, 2024 · CinCor Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. CIN-107 is a highly selective, oral small molecule inhibitor of aldosterone synthase, the enzyme responsible for the synthesis of ...
Webcincor pharma, inc. 2,905 followers on linkedin. developing the next generation of treatments for cardio-renal diseases. developing the next generation of treatments for … WebToday we announced an agreement to acquire CinCor Pharma, Inc., a US-based clinical-stage biopharmaceutical company, focused on developing novel…. Liked by Colin Cotton, MD. “It is an honor to ...
WebJan 9, 2024 · AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. The acquisition will bolster AstraZeneca’s cardiorenal pipeline by adding …
WebOct 12, 2024 · CinCor Pharma, Inc. (“CinCor”) today announced the completion of a $143 million Series B financing. The proceeds from this round will support the continued development of CIN-107, a highly selective, oral small molecule inhibitor of aldosterone synthase product candidate in development for the treatment of hypertension, primary …
WebFeb 21, 2024 · CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat. WALTHAM, Mass., Feb. 21, 2024 (GLOBE ... how many cubs can a wolf haveWebAbout Us. CinCor is a clinical-stage biopharmaceutical company focused on developing our lead clinical candidate, baxdrostat, for the treatment of hypertension and other cardio … how many cuboids to make a cubeWebNov 7, 2024 · CinCor, founded in 2024, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. … how many cubs can a bear haveWebCinCor Pharma, Inc. (sold to AstraZeneca) Nov 2024 - Nov 2024 1 year 1 month. Executive Vice President and Chief Financial Officer BioDelivery … high schools chester paWebDrug Company Leaders Condemn Ruling Invalidating F.D.A.’s Approval of Abortion Pill high schools cityWebI’m so delighted to share that AstraZeneca has topped the list of Best Places to Work in Middle East. This recognition is based on the … high schools close to my locationWebJan 9, 2024 · WALTHAM, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to acquire CinCor. Marc de Garidel, Chief Executive Officer at CinCor, said: “We are excited about the proposed acquisition … how many cubs can a lion have